2',3'-Dideoxyguanosine
| Title | Journal |
|---|---|
| Simultaneous determination of metacavir and its metabolites in rat plasma using high-performance liquid chromatography with tandem mass spectrometric detection (LC-MS/MS). | Biomedical chromatography : BMC 20120301 |
| Priming DNA replication from triple helix oligonucleotides: possible threestranded DNA in DNA polymerases. | Molecular biology international 20110101 |
| Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate. | Viruses 20101001 |
| Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content. | Journal of biomedical science 20100101 |
| A simple in vitro RNA editing assay for chloroplast transcripts using fluorescent dideoxynucleotides: distinct types of sequence elements required for editing of ndh transcripts. | The Plant journal : for cell and molecular biology 20060901 |
| In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. | Antimicrobial agents and chemotherapy 20050301 |
| Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors. | Molecular pharmacology 20040101 |
| Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine. | Antiviral chemistry & chemotherapy 20040101 |
| Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors. | Molecular pharmacology 20020201 |
| Dynamics of translesion DNA synthesis catalyzed by the bacteriophage T4 exonuclease-deficient DNA polymerase. | Biochemistry 20010619 |
| Crystal structures of a ddATP-, ddTTP-, ddCTP, and ddGTP- trapped ternary complex of Klentaq1: insights into nucleotide incorporation and selectivity. | Protein science : a publication of the Protein Society 20010601 |
| Synthesis and purification of oligonucleotide N3'-->P5' phosphoramidates and their phosphodiester and phosphorothioate chimeras. | Current protocols in nucleic acid chemistry 20010501 |
| Deoxynucleoside kinases encoded by the yaaG and yaaF genes of Bacillus subtilis. Substrate specificity and kinetic analysis of deoxyguanosine kinase with UTP as the preferred phosphate donor. | The Journal of biological chemistry 20010223 |
| Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138. | Virology 20010201 |
| The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir. | Antiviral research 19990101 |
| Effect of acyclic nucleoside phosphonates on the HIV-1 integrase in vitro. | Nucleosides & nucleotides 19990101 |
| Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1. | Journal of virology 19971101 |
| Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. | Antimicrobial agents and chemotherapy 19960501 |
| Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo. | Antimicrobial agents and chemotherapy 19960301 |
| Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720. | Journal of virology 19941201 |
| Resistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2''-dioxide)] (TSAO) derivatives is determined by the mutation Glu138-->Lys on the p51 subunit. | The Journal of biological chemistry 19941014 |
| Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. | Proceedings of the National Academy of Sciences of the United States of America 19930801 |
| Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection. | Antiviral research 19930601 |
| Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5'-(4'-amino-1',2'- oxathiole-2',2'-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues. | Molecular pharmacology 19930101 |
| HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. | Virology 19930101 |
| Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. | Antiviral research 19920701 |
| Synthesis and anti-HIV activity of isonucleosides. | Journal of medicinal chemistry 19920626 |
| Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs. | Biochemical pharmacology 19920122 |
| Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides. | Journal of medicinal chemistry 19910501 |
| Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro. | Proceedings of the National Academy of Sciences of the United States of America 19901201 |
| Cellular pharmacology and anti-HIV activity of 2',3'-dideoxyguanosine. | AIDS research and human retroviruses 19900901 |
| Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents. | Journal of medicinal chemistry 19900601 |
| Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS. | Journal of medicinal chemistry 19900501 |
| Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro. | Antimicrobial agents and chemotherapy 19900201 |
| Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells. | Biochemical pharmacology 19881001 |
| Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro. | Proceedings of the National Academy of Sciences of the United States of America 19880801 |
| Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1. | Antimicrobial agents and chemotherapy 19871201 |
| Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro. | Antimicrobial agents and chemotherapy 19871001 |
| Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro. | Biochemical and biophysical research communications 19870630 |
| Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. | Proceedings of the National Academy of Sciences of the United States of America 19860301 |